Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Prepaid Assets: 2014-2024

Historic Prepaid Assets for Viridian Therapeutics, Inc.\DE (VRDN) over the last 11 years, with Dec 2024 value amounting to $20.9 million.

  • Viridian Therapeutics, Inc.\DE's Prepaid Assets fell 21.92% to $11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year decrease of 21.92%. This contributed to the annual value of $20.9 million for FY2024, which is 131.81% up from last year.
  • Latest data reveals that Viridian Therapeutics, Inc.\DE reported Prepaid Assets of $20.9 million as of FY2024, which was up 131.81% from $9.0 million recorded in FY2023.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Prepaid Assets registered a high of $20.9 million during FY2024, and its lowest value of $2.0 million during FY2020.
  • Its 3-year average for Prepaid Assets is $12.1 million, with a median of $9.0 million in 2023.
  • As far as peak fluctuations go, Viridian Therapeutics, Inc.\DE's Prepaid Assets plummeted by 31.86% in 2020, and later surged by 137.39% in 2022.
  • Viridian Therapeutics, Inc.\DE's Prepaid Assets (Yearly) stood at $2.0 million in 2020, then soared by 39.30% to $2.7 million in 2021, then spiked by 137.39% to $6.5 million in 2022, then soared by 38.11% to $9.0 million in 2023, then spiked by 131.81% to $20.9 million in 2024.